Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoInnovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoInnovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 SAN FRANCISCO, U.S. and
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoRNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic
Will Zantac ruling make Delaware a mass torts magnet?
Reuters· 4 days agoIf you are mass torts lawyer, you should be paying attention to a trend that has emerged in...
More Salty Diets Linked to Higher Risk of Atopic Dermatitis
MedPage Today· 2 days agoA higher level of daily sodium intake was associated with an increased risk of atopic dermatitis, a...
Questions and Confessions: Usher Urges Early Testing for Type 1 Diabetes
US News & World Report· 2 days agoFor parents of a Type 1 diabetes patient, a diagnosis of the chronic autoimmune disease for their child can come as a shock. The award-winning singer, songwriter and actor recalls feeling “blindsided ...
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
MedPage Today· 6 days agoChina-based trial may present a hurdle to FDA approval, however
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 5 days agoEGFR testing now needed for all patients with stage III disease, experts say
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 5 days agoBack in 2021, Intellia made history when it successfully edited DNA inside the human body, working...
How Midas Lister Annie Lamont Became A Health Tech Heavy Hitter
Forbes· 3 days agoIn January 2001, the cofounders of AthenaHealth met with investor Annie Lamont to share some bad...
